BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 27, 2017
View Archived Issues
Chugai presents highlights of first quarter 2017
Read More
Capricor reports 6-month data from phase I/II trial of CAP-1002 for DMD
Read More
FDA clears Glenmark's IND for first-in-human study of omalizumab biosimilar GBR-310
Read More
European Commission approves Varuby
Read More
BioVie signs CRADA for phase IIa study of BIV-201 in refractory ascites
Read More
Janssen seeks Japanese approval for bedaquiline for multidrug-resistant pulmonary TB
Read More
Lilly initiates phase I study of LY-3321367 in advanced relapsed or refractory solid tumors
Read More
Q BioMed and Asdera sign licensing agreement for ASD-002 to treat rare pediatric nonverbal disorder
Read More
Phase III trial of intranasal midazolam in seizure clusters meets primary endpoint
Read More
FDA agrees on phase III program for inclisiran
Read More
Kiadis Pharma files MAA with EMA for ATIR-101 in blood cancers
Read More
AstraZeneca returns AZD-9412 rights to Synairgen
Read More
MDxHealth and Exact Sciences collaborate in epigenetics and molecular diagnostics
Read More
Retrophin initiates phase III study of fosmetpantotenate in patients with PKAN
Read More
Final 24-month data presented from the phase II OLE trial of patisiran
Read More
Phase III MYSTICOL study results presented for botulinum toxin type B in sialorrhea
Read More
Metrion Biosciences and Venomtech collaborate to identify novel ion channel modulators
Read More
Preclinical data for a novel tetravalent bispecific antibody, LY-3207447
Read More
Boehringer Ingelheim patents RORgamma t antagonists
Read More
LegoChem Biosciences reports beta-lactamase inhibitors
Read More
NeuroVive Pharmaceutical patent describes NFE2-related factor 2 activators
Read More
Proteostasis Therapeutics discloses CFTR channel correctors for cystic fibrosis
Read More
Astex and GlaxoSmithKline jointly develop agents for COPD
Read More
Roche reports glutamate transporter EAAT3 inhibitors
Read More
BeyondSpring enrolling U.S. patients in phase II/III study of plinabulin
Read More
Progress in merger of PharmAthene and Altimmune
Read More
Evotec, Sanofi describe oral cancer immunotherapeutic agent EVT-801
Read More
FDA designates TLC-178 as drug for rare pediatric disease for rhabdomyosarcoma
Read More